Clinical Trial Update: Low Dose IL-2 for Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating low-dose interleukin-2 for ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Low-dose Interleukin-2 (interleukin-2)

Snippet

Sponsor: Scott B. Snapper, MD PHD | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED | Results posted: 2020-12-19